Impact of NO on ET-1- and AM-induced inotropic responses: Potentiation by combined administration

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 279, Issue 2 48-2, 2000, Pages

  Kinnunen, Pietari ^a   Szokodi, István ^a,b   Nicholls, M Gary ^c   Ruskoaho, Heikki ^a,d  

^a UNIVERSITY OF OULU   (Finland)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c CHRISTCHURCH HOSPITAL   (New Zealand)

^d UNIVERSITY OF OULU   (Finland)

Author keywords

Myocardial contractility; N( ) nitro L arginine methyl ester; Perfused rat heart

Indexed keywords

ADRENOMEDULLIN; BOSENTAN; ENDOTHELIN 1; N(G) NITRO DEXTRO ARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; HEART MUSCLE CONTRACTILITY; INOTROPISM; MALE; MOLECULAR INTERACTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

EID: 0033862197     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.2000.279.2.r569     Document Type: Article

References (54)

1. Cloning and expression of a cDNA encoding an endothelin receptor
2. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system
3. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes
4. Induction of NO synthase in rat cardiac microvascular endothelial cells by IL-1 beta and IFN-gamma
5. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro
6. Nitric oxide synthase activities in human myocardium
7. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor
8. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP
9. The endothelial nitric-oxide synthase-caveolin regulatory cycle
10. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
11. Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: Potentiation of beta-adrenergic inotropic responsiveness
12. NOS: Modulator, not mediator of cardiac performance
13. Role of nitric oxide-cGMP pathway in adrenomedullin-induced vasodilation in the rat
14. Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy
15. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells
16. Production and secretion of adrenomedullin in cultured rat cardiac myocytes and nonmyocytes: Stimulation by interleukin-1beta and tumor necrosis factor-alpha
17. Negative inotropic effect of adrenomedullin in isolated adult rabbit cardiac ventricular myocytes
18. Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria
19. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure
20. Inhibition of nitric oxide synthase augments myocardial contractile responses to beta-adrenergic stimulation
21. Nitric oxide and cardiac function
22. Endothelin enhances the contractile responsiveness of adult rat ventricular myocytes to calcium by a pertussis toxin-sensitive pathway
23. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma
24. Mechanical deformation of vessel wall and shear stress determine the basal release of endothelium-derived relaxing factor in the intact rabbit coronary vascular bed
25. Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins
26. Contrasting inotropic effects of endogenous endothelin in the normal and failing human heart
27. Endothelin-1 is involved in stretch-induced early activation of B-type natriuretic peptide gene expression in atrial but not in ventricular myocytes: Acute effects of mixed ET(A)/ET(B) and AT1 receptor antagonists in vivo and in vitro
28. Paracrine effects of endocardial endothelial cells on myocyte contraction mediated via endothelin
29. Cardiovascular and renal effects of adrenomedullin in rats with heart failure
30. Increased production of nitric oxide in coronary arteries during congestive heart failure
31. An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat
32. Effect of endogenous nitric oxide on cardiac systolic and diastolic function during ischemia and reperfusion in the rat isolated perfused heart
33. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
34. Cardiovascular actions of adrenomedullin in conscious sheep
35. Characterization and localization of endothelial nitric oxide synthase using specific monoclonal antibodies
36. Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure
37. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog
38. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Marked increase in endothelin-1 production in the failing heart
39. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor
40. Nitric oxide synthase in cultured endocardial cells of the pig
41. In situ identification of messenger RNA of endothelial type nitric oxide synthase in rat cardiac myocytes
42. Paracrine modulation of heart cell function by endothelial cells
43. Adrenomedullin stimulates two signal transduction pathways, cAMP accumulation and Ca2+ mobilization, in bovine aortic endothelial cells
44. Endothelial cells actively synthesize and secrete adrenomedullin
45. Endothelin-1 is produced and secreted by neonatal rat cardiac myocytes in vitro
46. Inotropic effect of adrenomedullin in the isolated perfused rat heart
47. Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide
48. Exogenous effects and endogenous production of endothelin in cardiac myocytes: Potential significance in heart failure
49. Adrenomedullin: A possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes
50. Contractile responsiveness of ventricular myocytes to isoproterenol is regulated by induction of nitric oxide synthase activity in cardiac microvascular endothelial cells in heterotypic primary culture
51. Muscarinic and beta-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase
52. Endothelial cell regulation of contractility of the heart
53. Nitric oxide synthase in cardiac sarcoplasmic reticulum
54. A novel potent vasoconstrictor peptide produced by vascular endothelial cells